No attachments available.
Notice of Intent to Award to Sole Source - FSE On-Site Annual Preventative Maintenance
Contact and place of performance
Ruben Reyes
Atlanta, GA 30329
USA
The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to CEPHEID. This contract action is being conducted in accordance with FAR Overhaul Part 12.102, Restricting Competition. The Government determined that only one source is reasonably available to meet the current requirement based on the proprietary nature of the existing system configuration, compatibility...
View moreThe Government currently utilizes the Cepheid GeneXpert DX system, an automated platform used for rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples in support of public health testing activities.
The GeneXpert DX system has been integrated into the existing laboratory workflow and supports continuity of operations, surge testing capabilities, and ongoing Healthcare Wastewater sampling efforts. The system is also used to support comparative analysis against standard PCR testing methodologies.
Due to the proprietary nature of the GeneXpert DX platform, including manufacturer-specific components, software, maintenance requirements, and warranty conditions, the Government is seeking sources capable of providing authorized support and maintenance services for the existing equipment configuration.
The Government conducted market research, including review of available vendor information and communication with existing maintenance support resources, to identify potential sources capable of supporting the current system. Responses are being requested from vendors authorized to provide maintenance and support services for the Cepheid GeneXpert DX platform.
The Centers for Disease Control and Prevention intends to award a firm-fixed-price, sole-source contract to Cepheid for on-site annual preventive maintenance of the GeneXpert DX system. This automated platform is utilized in Atlanta, Georgia, for the rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples. The equipment is integrated into laboratory workflows to support public health testing, surge capacity, and comparative analysis against standard PCR methodologies. The government has determined that Cepheid is the only source reasonably available to meet this requirement due to the proprietary nature of the system configuration, manufacturer-specific software and components, and the need for continuity of ongoing operations.
This procurement is classified under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing and PSC J066 MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT. Although this notice of intent is not a request for competitive proposals, the government will consider responses from vendors authorized to provide maintenance and support services for the Cepheid GeneXpert DX platform. Interested parties must identify their capability to meet the requirement by submitting a response to the contract specialist, Ruben Reyes, at [email protected]. All information received by 8:00 AM on May 29, 2026, will be evaluated to determine whether a competitive procurement is warranted.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.